Upstream Biosciences Inc. Appoints University of British Columbia's Dr. Wyeth Wasserman To Advisory Board

Upstream Biosciences Inc. (OTC BB: UPBS) ("Upstream" or "the Company"), an emerging leader in the field of genetic diagnostics for cancer and the prediction of drug response, has announced today the appointment of Dr. Wyeth Wasserman to its scientific advisory board. Dr. Wasserman is a Professor at the University of British Columbia and senior scientist at the Centre for Molecular Medicine and Therapeutics (CMMT).

Back to news